The veterinary antimicrobial susceptibility testing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Veterinary Antimicrobial Susceptibility Testing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The veterinary antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $34.78 billion in 2023 to $37.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to environmental concerns, precision medicine demand, one health approach, consumer awareness, companion animal healthcare growth.
The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $50.45 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to antibiotic resistance mitigation, regulatory requirements, global health events impact, rising pet ownership. Major trends in the forecast period include innovative solutions, regulatory emphasis, zoonotic disease control, livestock industry standards.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report
Scope Of Veterinary Antimicrobial Susceptibility Testing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3.Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Veterinary Antimicrobial Susceptibility Testing Market Overview
Market Drivers –
The rising prevalence of zoonotic diseases is expected to propel the growth of the veterinary antimicrobial susceptibility testing market going forward. Zoonotic disease refers to a contagious illness that can spread from one species of animal to another, including from humans to animals (or from humans to humans). The rising prevalence of zoonotic diseases will create a need to test and determine the best animal medication. Veterinary antimicrobial susceptibility testing aids in choosing the best drug to treat bacterial infections in animals by checking treatment history and others. For instance, In July 2022, according to an article published by the world health organization, a US-based government agency, stated that there was a 64% rise in the number of zoonotic cases in Africa. Furthermore, zoonotic illnesses are on the increase both internationally and in India. These emerging infectious diseases in humans account for 60% of cases, with 816 zoonotic pathogens out of 1407 human pathogens. Therefore, the increasing prevalence of zoonotic diseases is driving the growth of the veterinary antimicrobial susceptibility testing market.
Market Trends –
Technological advancements have emerged as a key trend gaining popularity in the veterinary antimicrobial susceptibility testing market. Major companies operating in the veterinary market are focused on innovating new technologies to sustain their position in the market. Recently, the market has witnessed the use of advanced imaging techniques and algorithms for more accurate, reliable, and rapid veterinary AST (antimicrobial susceptibility testing). For instance, in October 2021, Thermo Fisher Scientific, a US-based science and technology company, along with Q-linea launched the ASTar System, a rapid antimicrobial susceptibility testing (rAST) system. The fully automated ASTar System monitors bacterial growth using imaging techniques and algorithms, eliminating the need for subculture, which can take an additional one to two days.
The veterinary antimicrobial susceptibility testing market covered in this report is segmented –
1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users
Get an inside scoop of the veterinary antimicrobial susceptibility testing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp
Regional Insights –
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2023. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the veterinary antimicrobial susceptibility testing market report are BioMérieux SA, Becton, Dickinson and Company, Bioguard Corporation, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Cepheid Inc., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, GenMark Diagnostics Inc., IDEXX Laboratories Inc., Luminex Corporation, Merck Co. & KGaA, Microbiologics Inc., Nanosphere Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.
1. Executive Summary
2. Veterinary Antimicrobial Susceptibility Testing Market Report Structure
3. Veterinary Antimicrobial Susceptibility Testing Market Trends And Strategies
4. Veterinary Antimicrobial Susceptibility Testing Market – Macro Economic Scenario
5. Veterinary Antimicrobial Susceptibility Testing Market Size And Growth
…..
27. Veterinary Antimicrobial Susceptibility Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
